<DOC>
	<DOCNO>NCT00904605</DOCNO>
	<brief_summary>Patients unilateral bilateral osteoarthritis knee participate Phase IV clinical trial ass efficacy Lidoderm compare celecoxib 200mg treat pain osteoarthritis knee .</brief_summary>
	<brief_title>Lidocaine Patch Versus Celecoxib Pain From Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . Had unilateral bilateral OA knee diagnose accord American College Rheumatology ( ACR ) criterion base clinical radiographic evidence OA ( presence osteophytes xray write evaluation ) 2 . Had functional capacity class rating I , II , III accord ACR classification 3 . Had normal 12lead electrocardiogram ( ECG ) without clinically significant abnormality heart rate , rhythm , conduction 4 . Had discontinue use analgesic medication ( include overthecounter [ OTC ] analgesic ) prior randomization ( patient allow limited use analgesic medication nonstudy pain ) 5 . At baseline visit , patient randomize active treatment average daily pain intensity score index joint 5 great ( 0 10 scale ) least 3 day 5 consecutive day immediately precede baseline visit ; 0 define `` pain '' 10 define `` pain bad ever imagine '' measure Question 5 BPI record diary . 6 . At baseline visit , patient randomize active treatment OA severity score index joint 7 great composite scale 0 24 measure Index Severity Osteoarthrosis Knee 1 . Had diagnose inflammatory arthritis , gout , pseudogout Paget 's disease investigator 's opinion would interfere assessment pain symptom OA 2 . Had elective surgery schedule occur 14week study 3 . Had serious medical condition require daily medication , anticonvulsant tricyclic antidepressant , may confound study result 4 . Had clinically significant joint disease prior joint replacement surgery index joint 5 . Had severe renal insufficiency ( creatinine clearance &lt; 30 mL/min ) 6 . Had moderate great hepatic impairment 7 . Had experience asthma , urticaria , allergictype reaction take aspirin NSAIDs 8 . Had prior history peptic ulcer disease and/or gastrointestinal bleeding 9 . Were take analgesic medication , glucosamine , chondroitin could discontinue study . Patients take medication prior study require discontinue use duration study . Patients use opioid analgesic study entry require taper medication . 10 . Were take longacting opioids opioids could discontinue first 5 day washout period . 11 . Were receive fluconazole lithium ( secondary drugdruginteraction risk ) 12 . Were take lidocainecontaining product could discontinue study 13 . Had previously fail treatment Lidoderm analgesic patch OA 14 . Had recently receive either corticosteroid injection ( within 8 week ) hyaluronic acid ( within 6 month ) study entry 15 . Were unable discontinue use topic drug apply knee 16 . Had previously fail treatment celecoxib two COX2 specific inhibitor celecoxib 17 . Were take class I antiarrhythmic drug ( e.g . mexiletine , tocainide )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>